North America Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
North America injectable drug delivery market is expected to reach USD 475,824.35 million by 2025 from USD 173,547.84 million in 2017, at a CAGR of 11.7% in the forecast period 2018 to 2025.
The major factors contributing to the growth of the market includes factors such rising cases of chronic diseases and due to rising demand of self-injection devices. On the other hand needle stick injuries and infections may hinder the growth of the market.
The key market players for North America injectable drug delivery market are listed below:
The North America injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation. The Injectable drug delivery market is dominated by formulations with 67.3% market share in 2018, growing at a CAGR of 11.7% and will cross USD 321,636.51 million by 2025.
On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others. The Injectable drug delivery market is dominated by hormonal disorders with 51.3% market share in 2018, growing at a CAGR of 11.6% and will cross USD 243,167.7 million by 2025. However, oncology segment is expected to grow at the highest CAGR of 12.7% in the forecast period, and is expected to reach USD 121,443.5 million in 2025 from USD 40,516.7 million in 2017.
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern. The Injectable drug delivery market is dominated by curative care with 91.7% market share in 2018, growing at a CAGR of 11.8% and will cross USD 440,541.8 million by 2025.
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system. The Injectable drug delivery market is dominated by skin with 43.2% market share in 2018, growing with highest CAGR of 12.3% and will cross USD 215,342.4 million by 2025.
On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. The Injectable drug delivery market is dominated by hospitals & clinics with 64.6% market share in 2018, growing at a CAGR of 11.7% and will cross USD 307,853.9 million by 2025. However, home healthcare settings companies segment is expected to grow at the highest CAGR of 12.3% in the forecast period, and is expected to reach USD 113,830.3 million in 2025 from USD 39,257.1 million in 2017
On the basis of distribution channel, the market is classified into hospital pharmacies, pharmacy store, and direct tender and online pharmacy. The Injectable drug delivery market is dominated by direct tenders with 65.1% market share in 2018, growing the highest CAGR of 11.9% and will cross USD 315,277.4 million by 2025.
Based on geography, the North America injectable drug delivery market is segmented into geographical regions, such as
The report covers the present scenario and the growth prospects of the North America injectable drug delivery market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report
The major factors contributing to the growth of the market includes factors such rising cases of chronic diseases and due to rising demand of self-injection devices. On the other hand needle stick injuries and infections may hinder the growth of the market.
The key market players for North America injectable drug delivery market are listed below:
- Baxter International, Inc.,
- Becton Dickinson and Company,
- Gerresheimer AG,
- Pfizer, Inc.,
- Schott AG,
- Alkermes Plc.,
- Eli Lilly and Company,
- Sandoz,
- Terumo Corporation,
- Teva Pharmaceuticals Industries Ltd.
- Ypsomed,
- Bespak
- Type
- Usage Pattern
- End-User
- Mode of Administration
- Distribution Channel
- Application
- Geography
The North America injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation. The Injectable drug delivery market is dominated by formulations with 67.3% market share in 2018, growing at a CAGR of 11.7% and will cross USD 321,636.51 million by 2025.
On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others. The Injectable drug delivery market is dominated by hormonal disorders with 51.3% market share in 2018, growing at a CAGR of 11.6% and will cross USD 243,167.7 million by 2025. However, oncology segment is expected to grow at the highest CAGR of 12.7% in the forecast period, and is expected to reach USD 121,443.5 million in 2025 from USD 40,516.7 million in 2017.
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern. The Injectable drug delivery market is dominated by curative care with 91.7% market share in 2018, growing at a CAGR of 11.8% and will cross USD 440,541.8 million by 2025.
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system. The Injectable drug delivery market is dominated by skin with 43.2% market share in 2018, growing with highest CAGR of 12.3% and will cross USD 215,342.4 million by 2025.
On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. The Injectable drug delivery market is dominated by hospitals & clinics with 64.6% market share in 2018, growing at a CAGR of 11.7% and will cross USD 307,853.9 million by 2025. However, home healthcare settings companies segment is expected to grow at the highest CAGR of 12.3% in the forecast period, and is expected to reach USD 113,830.3 million in 2025 from USD 39,257.1 million in 2017
On the basis of distribution channel, the market is classified into hospital pharmacies, pharmacy store, and direct tender and online pharmacy. The Injectable drug delivery market is dominated by direct tenders with 65.1% market share in 2018, growing the highest CAGR of 11.9% and will cross USD 315,277.4 million by 2025.
Based on geography, the North America injectable drug delivery market is segmented into geographical regions, such as
- U.S.
- Canada
- Mexico
The report covers the present scenario and the growth prospects of the North America injectable drug delivery market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report
1 INTRODUCTION
1.1 Overview Of North America Injectable Drug Delivery Market
1.2 Currency And Pricing
1.3 Limitation
1.4 Markets Covered
2 MARKET SEGMENTATION
2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 Secondary Sources
2.8 Assumptions
3 MARKET OVERVIEW
3.1 Drivers
3.1.1 Rising Cases Of Chronic Diseases
3.1.2 Rising Demand Of Self-Injection Devices
3.1.3 Growth Of Biologics Market
3.1.4 Technological Advancements And Innovations In Drug Delivery Market
3.2 Restraints
3.2.1 Needlestick Injuries And Infections
3.2.2 High Cost Of Development
3.2.3 Strict Regulatory Framework
3.3 Opportunity
3.3.1 Increasing Demand For Generic And Biosimilar Drugs
3.3.1.1 Generics
3.3.1.2 Biosimilars
3.3.2 Increasing Demand For Contraceptive Injectables
3.3.3 Increasing Demand For Self-Administration Of Drugs
3.4 Challenges
3.4.1 Alternative Route Of Drug Administration
3.4.2 Product Recall
3.4.3 Stability Of Products
3.4.4 Sterility Of Injections
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY TYPE
6.1 Overview
6.2 Injectable Drug Delivery Devices
6.2.1 Conventional Injection Devices
6.2.1.1 Conventional Injection Devices, By Material
6.2.1.1.1 Glass
6.2.1.1.2 Plastic
6.2.1.2 Conventional Injection Devices, By Product
6.2.1.2.1 Fillable Syringes
6.2.1.2.2 Prefilled Syringes
6.2.1.3 Conventional Injection Devices, By Usability
6.2.1.3.1 Reusable Syringes
6.2.1.3.2 Disposable Syringes
6.2.2 Self Injection Devices
6.2.2.1 Needle Free Injectors (Nfi)
6.2.2.2 Needle Free Injectors, By Product
6.2.2.2.1 Fillable Needle-Free Injectors
6.2.2.2.2 Prefilled Needle-Free Injectors
6.2.2.3 Needle Free Injectors, By Technology
6.2.2.3.1 Jet Based Needle Free Injectors:
6.2.2.3.2 Spring Based Needle Free Injectors:
6.2.2.3.3 Laser Based Needle Free Injectors:
6.2.2.3.4 Vibration Based Needle Free Injectors:
6.2.2.4 Needle Free Injectors, By Usability
6.2.2.4.1 Reusable Needle-Free Injectors
6.2.2.4.2 Disposable Needle-Free Injectors
6.2.2.5 Auto Injectors
6.2.2.6 Auto Injectors, By Product
6.2.2.6.1 Fillable Auto Injectors
6.2.2.6.2 Pre-Filled Autoinjectors
6.2.2.7 Auto Injectors, By Technology
6.2.2.7.1 Automated Auto Injectors
6.2.2.7.2 Manual Auto Injectors
6.2.2.8 Auto Injectors, By Design
6.2.2.8.1 Standardized Auto Injectors
6.2.2.8.2 Automated Autoinjectors
6.2.2.9 Auto Injectors, By Usability
6.2.2.9.1 Reusable Autoinjectors
6.2.2.9.2 Disposable Autoinjectors
6.2.2.10 Pen Injectors
6.2.2.11 Pen Injectors, By Product
6.2.2.11.1 Single Chambered Pen Injectors
6.2.2.11.2 Dual Chambered Pen Injectors
6.2.2.12 Pen Injectors, By Design
6.2.2.12.1 Standard Pen Injectors
6.2.2.12.2 Customized Pen Injectors
6.2.2.13 Pen Injectors, By Usability
6.2.2.13.1 Reusable Pen Injectors
6.2.2.13.2 Disposable Pen Injectors
6.2.2.14 Wearable Injectors
6.2.2.14.1 Other Devices
6.3 Injectable Drug Delivery Formulation
6.3.1 Conventional Drug Delivery Formulations
6.3.1.1 Solutions
6.3.1.2 Reconstituted/Lyophilized Formulations
6.3.1.3 Suspensions
6.3.1.4 Emulsions
6.3.2 Novel Drug Delivery Formulations
6.3.2.1 Colloidal Dispersions
6.3.2.1.1 Niosomes
6.3.2.1.2 Liposomes
6.3.2.1.3 Polymeric Mixed Micelles
6.3.2.1.4 Nanoparticles
6.3.2.1.5 Nanosuspensions
6.3.2.1.6 Nanoemulsions/Microemulsions
6.3.2.1.7 Solid Lipid Nanoparticles
6.3.2.2 Microparticles
6.3.2.2.1 Microspheres
6.3.2.2.2 Microcapsules
6.3.2.3 Long Acting Injection Formulation
7 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
7.1 Overview
7.2 North America Injectable Drug Delivery Market, By Application
7.3 Hormonal Disorders
7.3.1 Injectable Drugs For Diabetes
7.3.2 Injectable Drugs For Anemia
7.3.3 Injectable Drugs For Reproductive Health Disease
7.3.4 Injectable Drugs For Antithrombotic/Thrombolytic Therapy
7.3.5 Injectable Drugs For Osteoporosis
7.3.6 Injectable Drugs For Growth Hormone Disorders (Ghd)
7.4 Oncology
7.5 Autoimmune Diseases
7.5.1 Injectable Drugs For Rheumatoid Arthritis
7.5.2 Injectable Drugs For Multiple Sclerosis
7.5.3 Injectable Drugs For Crohn’S Diseases
7.5.4 Injectable Drugs For Psoriasis
7.5.5 Injectable Drugs For Other Autoimmune Diseases
7.6 Orphan Disease
7.7 Other Applications
7.7.1 Injectable Drugs For Pain Management
7.7.2 Injectable Drugs For Allergy Treatment
7.7.3 Injectable Drugs For Aesthetic Treatments
7.7.4 Injectable Drugs For Hepatitis C
7.7.5 Injectable Drugs For Hemophilia
8 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN
8.1 Overview
8.2 Curative Care
8.3 Immunizations
8.4 Other Usage Pattern
9 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION
9.1 Overview
9.2 Skin
9.3 Circulatory/ Muskoskeletal
9.4 Organs
9.5 Central Nervous System
10 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END USER
10.1 Overview
10.2 Hospitals And Clinics
10.3 Home Healthcare Settings
10.4 Research Laboratories
10.5 Pharmaceutical And Biotechnological Companies
10.6 Other End Users
11 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
11.1 Overview
11.1.1 Hospital Pharmacy
11.1.2 Pharmacy Stores
11.1.3 Direct Tender
11.1.4 Online Pharmacy
12 NORTH AMERICA INJECTABLE DRUG DILIVERY MARKET BY GEOGRAPHY
12.1.1 U.S. Injectable Drug Delivery Market
12.1.2 Canada Injectable Drug Delivery Market
12.1.3 Mexico Injectable Drug Delivery Market
13 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, COMPANY SHARE
13.1 Company Share Analysis: North America
14 COMPANY PROFILES
14.1 Becton, Dickinson And Company
14.1.1 Company Overview
14.1.1.1 Drivers Explained
14.1.1.2 Weaknesses Explained
14.1.1.3 Oppurtunities Explained
14.1.1.4 Threats Explained
14.1.2 Product Portfolio
14.1.3 Recent Developments
14.2 Pfizer
14.2.1 Company Overview
14.2.1.1 Drivers Explained
14.2.1.2 Weaknesses Explained
14.2.1.3 Oppurtunities Explained
14.2.1.4 Threats Explained
14.2.2 Product Portfolio
14.2.3 Recent Developments
14.3 Baxter International
14.3.1 Company Overview
14.3.1.1 Drivers Explained
14.3.1.2 Weaknesses Explained
14.3.1.3 Oppurtunities Explained
14.3.1.4 Threats Explained
14.3.2 Product Portfolio
14.3.3 Recent Developments
14.4 Gerresheimer Ag
14.4.1 Company Overview
14.4.2 Product Portfolio
14.4.3 Recent Developments
14.5 Schott Ag Inc.
14.5.1 Company Overview
14.5.2 Product Portfolio
14.5.3 Recent Developments
14.6 Alkermes Inc.
14.6.1 Company Overview
14.6.2 Product Portfolio
14.6.3 Recent Developments
14.7 Antares Pharma
14.7.1 Company Overview
14.7.2 Product Portfolio
14.7.3 Recent Developments
14.8 Bespak (Subsidiary Of Consort Medical Company)
14.8.1 Company Overview
14.8.2 Product Portfolio
14.8.3 Recent Developments
14.9 Elcam Medical
14.9.1 Company Overview
14.9.2 Product Portfolio
14.9.3 Recent Developments
14.10 Eli Lilly And Company
14.10.1 Company Overview
14.10.1.1 Drivers Explained
14.10.1.2 Weaknesses Explained
14.10.1.3 Oppurtunities Explained
14.10.1.4 Threats Explained
14.10.2 Product Portfolio
14.10.3 Recent Developments
14.11 Haselmeier
14.11.1 Company Overview
14.11.2 Product Portfolio
14.11.3 Recent Developments
14.12 Mylan N.V.
14.12.1 Company Overview
14.12.2 Product Portfolio
14.12.3 Recent Developments
14.13 Novo Nordisk
14.13.1 Company Overview
14.13.2 Product Portfolio
14.13.3 Recent Developments
14.14 Owen Mumford Ltd
14.14.1 Company Overview
14.14.2 Product Portfolio
14.14.3 Recent Developments
14.15 Sandoz International Gmbh
14.15.1 Company Overview
14.15.2 Product Portfolio
14.15.3 Recent Developments
14.16 Sanofi
14.16.1 Company Overview
14.16.2 Product Portfolio
14.16.3 Recent Developments
14.17 Terumo Corporation
14.17.1 Company Overview
14.17.2 Product Portfolio
14.17.3 Recent Developments
14.18 Teva Pharmaceutical
14.18.1 Company Overview
14.18.1.1 Drivers Explained
14.18.1.2 Weaknesses Explained
14.18.1.3 Oppurtunities Explained
14.18.1.4 Threats Explained
14.18.2 Product Portfolio
14.18.3 Recent Developments
14.19 West Pharmaceutical Services, Inc
14.19.1 Company Overview
14.19.2 Product Portfolio
14.19.3 Recent Developments
14.20 Ypsomed Holding Ag
14.20.1 Company Overview
14.20.2 Product Portfolio
14.20.3 Recent Developments
15 RELATED REPORTS
1.1 Overview Of North America Injectable Drug Delivery Market
1.2 Currency And Pricing
1.3 Limitation
1.4 Markets Covered
2 MARKET SEGMENTATION
2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 Secondary Sources
2.8 Assumptions
3 MARKET OVERVIEW
3.1 Drivers
3.1.1 Rising Cases Of Chronic Diseases
3.1.2 Rising Demand Of Self-Injection Devices
3.1.3 Growth Of Biologics Market
3.1.4 Technological Advancements And Innovations In Drug Delivery Market
3.2 Restraints
3.2.1 Needlestick Injuries And Infections
3.2.2 High Cost Of Development
3.2.3 Strict Regulatory Framework
3.3 Opportunity
3.3.1 Increasing Demand For Generic And Biosimilar Drugs
3.3.1.1 Generics
3.3.1.2 Biosimilars
3.3.2 Increasing Demand For Contraceptive Injectables
3.3.3 Increasing Demand For Self-Administration Of Drugs
3.4 Challenges
3.4.1 Alternative Route Of Drug Administration
3.4.2 Product Recall
3.4.3 Stability Of Products
3.4.4 Sterility Of Injections
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY TYPE
6.1 Overview
6.2 Injectable Drug Delivery Devices
6.2.1 Conventional Injection Devices
6.2.1.1 Conventional Injection Devices, By Material
6.2.1.1.1 Glass
6.2.1.1.2 Plastic
6.2.1.2 Conventional Injection Devices, By Product
6.2.1.2.1 Fillable Syringes
6.2.1.2.2 Prefilled Syringes
6.2.1.3 Conventional Injection Devices, By Usability
6.2.1.3.1 Reusable Syringes
6.2.1.3.2 Disposable Syringes
6.2.2 Self Injection Devices
6.2.2.1 Needle Free Injectors (Nfi)
6.2.2.2 Needle Free Injectors, By Product
6.2.2.2.1 Fillable Needle-Free Injectors
6.2.2.2.2 Prefilled Needle-Free Injectors
6.2.2.3 Needle Free Injectors, By Technology
6.2.2.3.1 Jet Based Needle Free Injectors:
6.2.2.3.2 Spring Based Needle Free Injectors:
6.2.2.3.3 Laser Based Needle Free Injectors:
6.2.2.3.4 Vibration Based Needle Free Injectors:
6.2.2.4 Needle Free Injectors, By Usability
6.2.2.4.1 Reusable Needle-Free Injectors
6.2.2.4.2 Disposable Needle-Free Injectors
6.2.2.5 Auto Injectors
6.2.2.6 Auto Injectors, By Product
6.2.2.6.1 Fillable Auto Injectors
6.2.2.6.2 Pre-Filled Autoinjectors
6.2.2.7 Auto Injectors, By Technology
6.2.2.7.1 Automated Auto Injectors
6.2.2.7.2 Manual Auto Injectors
6.2.2.8 Auto Injectors, By Design
6.2.2.8.1 Standardized Auto Injectors
6.2.2.8.2 Automated Autoinjectors
6.2.2.9 Auto Injectors, By Usability
6.2.2.9.1 Reusable Autoinjectors
6.2.2.9.2 Disposable Autoinjectors
6.2.2.10 Pen Injectors
6.2.2.11 Pen Injectors, By Product
6.2.2.11.1 Single Chambered Pen Injectors
6.2.2.11.2 Dual Chambered Pen Injectors
6.2.2.12 Pen Injectors, By Design
6.2.2.12.1 Standard Pen Injectors
6.2.2.12.2 Customized Pen Injectors
6.2.2.13 Pen Injectors, By Usability
6.2.2.13.1 Reusable Pen Injectors
6.2.2.13.2 Disposable Pen Injectors
6.2.2.14 Wearable Injectors
6.2.2.14.1 Other Devices
6.3 Injectable Drug Delivery Formulation
6.3.1 Conventional Drug Delivery Formulations
6.3.1.1 Solutions
6.3.1.2 Reconstituted/Lyophilized Formulations
6.3.1.3 Suspensions
6.3.1.4 Emulsions
6.3.2 Novel Drug Delivery Formulations
6.3.2.1 Colloidal Dispersions
6.3.2.1.1 Niosomes
6.3.2.1.2 Liposomes
6.3.2.1.3 Polymeric Mixed Micelles
6.3.2.1.4 Nanoparticles
6.3.2.1.5 Nanosuspensions
6.3.2.1.6 Nanoemulsions/Microemulsions
6.3.2.1.7 Solid Lipid Nanoparticles
6.3.2.2 Microparticles
6.3.2.2.1 Microspheres
6.3.2.2.2 Microcapsules
6.3.2.3 Long Acting Injection Formulation
7 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
7.1 Overview
7.2 North America Injectable Drug Delivery Market, By Application
7.3 Hormonal Disorders
7.3.1 Injectable Drugs For Diabetes
7.3.2 Injectable Drugs For Anemia
7.3.3 Injectable Drugs For Reproductive Health Disease
7.3.4 Injectable Drugs For Antithrombotic/Thrombolytic Therapy
7.3.5 Injectable Drugs For Osteoporosis
7.3.6 Injectable Drugs For Growth Hormone Disorders (Ghd)
7.4 Oncology
7.5 Autoimmune Diseases
7.5.1 Injectable Drugs For Rheumatoid Arthritis
7.5.2 Injectable Drugs For Multiple Sclerosis
7.5.3 Injectable Drugs For Crohn’S Diseases
7.5.4 Injectable Drugs For Psoriasis
7.5.5 Injectable Drugs For Other Autoimmune Diseases
7.6 Orphan Disease
7.7 Other Applications
7.7.1 Injectable Drugs For Pain Management
7.7.2 Injectable Drugs For Allergy Treatment
7.7.3 Injectable Drugs For Aesthetic Treatments
7.7.4 Injectable Drugs For Hepatitis C
7.7.5 Injectable Drugs For Hemophilia
8 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN
8.1 Overview
8.2 Curative Care
8.3 Immunizations
8.4 Other Usage Pattern
9 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION
9.1 Overview
9.2 Skin
9.3 Circulatory/ Muskoskeletal
9.4 Organs
9.5 Central Nervous System
10 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END USER
10.1 Overview
10.2 Hospitals And Clinics
10.3 Home Healthcare Settings
10.4 Research Laboratories
10.5 Pharmaceutical And Biotechnological Companies
10.6 Other End Users
11 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
11.1 Overview
11.1.1 Hospital Pharmacy
11.1.2 Pharmacy Stores
11.1.3 Direct Tender
11.1.4 Online Pharmacy
12 NORTH AMERICA INJECTABLE DRUG DILIVERY MARKET BY GEOGRAPHY
12.1.1 U.S. Injectable Drug Delivery Market
12.1.2 Canada Injectable Drug Delivery Market
12.1.3 Mexico Injectable Drug Delivery Market
13 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, COMPANY SHARE
13.1 Company Share Analysis: North America
14 COMPANY PROFILES
14.1 Becton, Dickinson And Company
14.1.1 Company Overview
14.1.1.1 Drivers Explained
14.1.1.2 Weaknesses Explained
14.1.1.3 Oppurtunities Explained
14.1.1.4 Threats Explained
14.1.2 Product Portfolio
14.1.3 Recent Developments
14.2 Pfizer
14.2.1 Company Overview
14.2.1.1 Drivers Explained
14.2.1.2 Weaknesses Explained
14.2.1.3 Oppurtunities Explained
14.2.1.4 Threats Explained
14.2.2 Product Portfolio
14.2.3 Recent Developments
14.3 Baxter International
14.3.1 Company Overview
14.3.1.1 Drivers Explained
14.3.1.2 Weaknesses Explained
14.3.1.3 Oppurtunities Explained
14.3.1.4 Threats Explained
14.3.2 Product Portfolio
14.3.3 Recent Developments
14.4 Gerresheimer Ag
14.4.1 Company Overview
14.4.2 Product Portfolio
14.4.3 Recent Developments
14.5 Schott Ag Inc.
14.5.1 Company Overview
14.5.2 Product Portfolio
14.5.3 Recent Developments
14.6 Alkermes Inc.
14.6.1 Company Overview
14.6.2 Product Portfolio
14.6.3 Recent Developments
14.7 Antares Pharma
14.7.1 Company Overview
14.7.2 Product Portfolio
14.7.3 Recent Developments
14.8 Bespak (Subsidiary Of Consort Medical Company)
14.8.1 Company Overview
14.8.2 Product Portfolio
14.8.3 Recent Developments
14.9 Elcam Medical
14.9.1 Company Overview
14.9.2 Product Portfolio
14.9.3 Recent Developments
14.10 Eli Lilly And Company
14.10.1 Company Overview
14.10.1.1 Drivers Explained
14.10.1.2 Weaknesses Explained
14.10.1.3 Oppurtunities Explained
14.10.1.4 Threats Explained
14.10.2 Product Portfolio
14.10.3 Recent Developments
14.11 Haselmeier
14.11.1 Company Overview
14.11.2 Product Portfolio
14.11.3 Recent Developments
14.12 Mylan N.V.
14.12.1 Company Overview
14.12.2 Product Portfolio
14.12.3 Recent Developments
14.13 Novo Nordisk
14.13.1 Company Overview
14.13.2 Product Portfolio
14.13.3 Recent Developments
14.14 Owen Mumford Ltd
14.14.1 Company Overview
14.14.2 Product Portfolio
14.14.3 Recent Developments
14.15 Sandoz International Gmbh
14.15.1 Company Overview
14.15.2 Product Portfolio
14.15.3 Recent Developments
14.16 Sanofi
14.16.1 Company Overview
14.16.2 Product Portfolio
14.16.3 Recent Developments
14.17 Terumo Corporation
14.17.1 Company Overview
14.17.2 Product Portfolio
14.17.3 Recent Developments
14.18 Teva Pharmaceutical
14.18.1 Company Overview
14.18.1.1 Drivers Explained
14.18.1.2 Weaknesses Explained
14.18.1.3 Oppurtunities Explained
14.18.1.4 Threats Explained
14.18.2 Product Portfolio
14.18.3 Recent Developments
14.19 West Pharmaceutical Services, Inc
14.19.1 Company Overview
14.19.2 Product Portfolio
14.19.3 Recent Developments
14.20 Ypsomed Holding Ag
14.20.1 Company Overview
14.20.2 Product Portfolio
14.20.3 Recent Developments
15 RELATED REPORTS
LIST OF TABLES
Table 1 Examples Of Technological Advancements ()(2013- 2017)
Table 2 List Of Product Recall Drugs
Table 3 North America Injectable Drug Delivery Market, By Type, 2016 – 2025(Usd Million)
Table 4 North America Injectable Drug Delivery Devices Market, By Type, 2016 – 2025 (Usd Million)
Table 5 North America Conventional Drug Delivery Market, By Material, 2016 – 2025 (Usd Million)
Table 6 North America Conventional Drug Delivery Market, By Product, 2016 – 2025 (Usd Million)
Table 7 North America Conventional Drug Delivery Market, By Usability, 2016 – 2025(Usd Million)
Table 8 North America Self Injection Devices Market, By Product Type, 2016 – 2025 (Usd Million)
Table 9 North America Needle Free Injector Devices Market, By Product, 2016 – 2025 (Usd Million)
Table 10 North America Needle Free Injector Devices Market, By Technology, 2016– 2025 (Usd Million)
Table 11 North America Needle Free Injectors Device Arket, By Usability, 2016 – 2025 (Usd Million)
Table 12 North America Auto Injector Devices Market, By Product, 2016 – 2025 (Usd Million)
Table 13 North America Auto Injector Devices Market, By Technology, 2016 – 2025 (Usd Million)
Table 14 North America Auto Injector Devices Market, By Design, 2016 – 2025 (Usd Million)
Table 15 North America Auto Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 16 North America Pen Injector Devices Market, By Product, 2016 – 2025 (Usd Million)
Table 17 North America Pen Injector Devices Market, By Design, 2016 – 2025 (Usd Million)
Table 18 North America Pen Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 19 North America Injectable Drug Delivery Formulation Market, By Type, 2016 – 2025 (Usd Million)
Table 20 List Of Some Of The Lyophilized Formulations
Table 21 List Of Some Of The Emulsions
Table 22 North America Conventional Drug Delivery Formulation Market, By Product Type, 2016– 2025 (Usd Million)
Table 23 North America Novel Drug Delivery Formulation Market, By Product Type,2016 – 2025 (Usd Million)
Table 24 North America Colloidal Novel Drug Delivery Formulation Market, By Product Type, 20156– 2025 (Usd Million)
Table 25 List Of Some Of The Niosomes
Table 26 List Of Some Of The Liposomes
Table 27 List Of Some Of The Polymeric Mixed Micelles Drug Manufacturer
Table 28 List Of Nanosuspension Drug Manufacturer
Table 29 List Of Some Of The Nanoemulsions/Microemulsions Drug Manufacturer
Table 30 List Of Some Of The Solid Lipid Nanoparticles Drug Manufacturer
Table 31 North America Nanoparticle Colloidal Drug Delivery Formulation Market, By Product, 2016 – 2025 (Usd Million)
Table 32 List Of Some Of The Microspheres Drug Manufacturer
Table 33 North America Microparticles Colloidal Novel Drug Delivery Formulation Market, By Product Type, 20156– 2025 (Usd Million)
Table 34 List Of Some Of The First Generation Long Acting Injection
Table 35 List Of Some Of The Second Generation Long Acting Injection:
Table 36 North America Injectable Drug Delivery Application Market, By Application, 2016 – 2025 (Usd Million)
Table 37 North America Injectable Drug Delivery Application Market, By Hormonal Disorders Type, 2016 – 2025 (Usd Billion)
Table 38 North America Autoimmune Disease Injectable Drug Delivery Application Market, By Autoimmune Disease Type, 2016 – 2025 (Usd Billion)
Table 39 List Of Orphan Disease In India (2010)
Table 40 North America Others Injectable Drug Delivery Application Market, By Others Type, 2016 – 2025 (Usd Billion)
Table 41 North Americainjectable Drug Delivery Usage Pattern Market, By Type, 2015 – 2024 (Usd Million)
Table 42 North America Injectable Drug Delivery Market, By Mode Of Administration, 2016 – 2025 (Usd Million)
Table 43 North America Injectable Drug Delivery Market, By End User, 2016– 2025 (Usd Million)
Table 44 North America Injectable Drug Delivery Market, By Distribution Channel, 2016 – 2025 (Usd Million)
Table 45 North America Injectable Drug Delivery Market, By Country, 2016 – 2025 (Usd Million)
Table 46 North America Injectable Drug Delivery Market, By Type, 2016 – 2025 (Usd Million)
Table 47 North America Injectable Drug Delivery Devices Market, By Product Type, 2016 – 2025 (Usd Million)
Table 48 North America Conventional Injectable Drug Delivery Device Market, By Material,2016 – 2025 (Usd Million)
Table 49 North America Conventional Injectable Drug Delivery Device Market, By Product Type, 2016 – 2025 (Usd Million)
Table 50 North America Conventional Injectable Drug Delivery Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 51 North America Self Injection Device Market, By Type,2016 – 2025 (Usd Million)
Table 52 North America Needle Free Injectors (Nfi) Device Market, By Product,2016 – 2025 (Usd Million)
Table 53 North America Needle Free Injectors (Nfi) Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 54 North America Needle Free Injectors (Nfi) Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 55 North America Auto Injectorsdevice Market, By Product, 2016 – 2025 (Usd Million)
Table 56 North America Auto Injectors Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 57 North America Auto Injectors Device Market, By Design, 2016 – 2025 (Usd Million)
Table 58 North America Auto Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 59 North America Pen Injectors Device Market, By Product, 2016 – 2025 (Usd Million)
Table 60 North America Pen Injectors Device Market, By Design,2016– 2025 (Usd Million)
Table 61 North America Pen Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 62 North America Injectable Drug Delivery Formulation Market, By Type, 2016– 2025 (Usd Million)
Table 63 North America Conventionaldrug Delivery Formulations, By Product Type 2016 – 2025 (Usd Million)
Table 64 North America Noveldrug Delivery Formulations, By Product Type, 2016 – 2025 (Usd Million)
Table 65 North America Colloidaldispersion Drug Delivery Formulation, By Product Type,20156– 2025 (Usd Million)
Table 66 North America Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Type, 2016– 2025 (Usd Million)
Table 67 North America Micro Particles Drug Delivery Formulations, By Type, 2016– 2025 (Usd Million)
Table 68 North America Injectable Drug Delivery Market, By Application, 2016 – 2025 (Usd Million)
Table 69 North America Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Disease Type, 2016 – 2025 (Usd Million)
Table 70 North America Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016 – 2025 (Usd Million)
Table 71 North America Others Injectable Drug Delivery Market, By Others Type, 2016 – 2025 (Usd Million)
Table 72 North America Injectable Drug Delivery Market, By Usage Pattern, 2016– 2025 (Usd Million)
Table 73 North America Injectable Drug Delivery Market, By Mode Of Administration, 2016– 2025 (Usd Million)
Table 74 North America Injectable Drug Delivery Market, By End User, 2016– 2025 (Usd Million)
Table 75 North America Injectable Drug Delivery Market, By Distribution Channel, 2016– 2025 (Usd Million)
Table 76 U.S. Injectable Drug Delivery Market, By Product Type, 2016 – 2025 (Usd Million)
Table 77 U.S. Injectable Drug Delivery Devices Market, By Product Type, 2016 – 2025 (Usd Million)
Table 78 U.S. Conventional Injectable Drug Delivery Device Market, By Product Type,2016 – 2025 (Usd Million)
Table 79 U.S. Conventional Injectable Drug Delivery Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 80 U.S. Self Injection Device Market, By Type, 2016 – 2025 (Usd Million)
Table 81 U.S. Needle Free Injectors (Nfi) Device Market, By Product,2016 – 2025 (Usd Million)
Table 82 U.S. Needle Free Injectors (Nfi) Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 83 U.S. Needle Free Injectors (Nfi) Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 84 U.S. Auto Injectorsdevice Market, By Product, 2016 – 2025 (Usd Million)
Table 85 U.S. Auto Injectors Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 86 U.S. Auto Injectors Device Market, By Design, 2016 – 2025 (Usd Million)
Table 87 U.S. Auto Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 88 U.S. Pen Injectors Device Market, By Product, 2016 – 2025 (Usd Million)
Table 89 U.S. Pen Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 90 U.S. Injectable Drug Delivery Formulation Market, By Product Type, 2016– 2025 (Usd Million)
Table 91 U.S. Conventionaldrug Delivery Formulations, By Product Type 2016 – 2025 (Usd Million)
Table 92 U.S. Noveldrug Delivery Formulations, By Product Type 2016 – 2025 (Usd Million)
Table 93 U.S. Colloidaldispersion Drug Delivery Formulation, By Product Type, 2016 – 2025 (Usd Million)
Table 94 U.S. Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Product Type, 2016– 2025 (Usd Million)
Table 95 U.S. Micro Particles Drug Delivery Formulations, By Product Type, 2016– 2025 (Usd Million)
Table 96 U.S. Injectable Drug Delivery Market, By Application,2016 – 2025 (Usd Million)
Table 97 U.S. Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Disease Type, 20156– 2025 (Usd Million)
Table 98 U.S. Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016 – 2025 (Usd Million)
Table 99 U.S. Others Injectable Drug Delivery Market, By Others Type, 2016 – 2025 (Usd Million)
Table 100 U.S. Injectable Drug Delivery Market, By Usage Pattern, 2016– 2025 (Usd Million)
Table 101 U.S. Injectable Drug Delivery Market, By Mode Of Administration, 2016– 2025 (Usd Million)
Table 102 U.S. Injectable Drug Delivery Market, By End User, 2016– 2025 (Usd Million)
Table 103 U.S. Injectable Drug Delivery Market, By Distribution Channel 2016– 2025 (Usd Million)
Table 104 Canada Injectable Drug Delivery Market, By Type, 20156– 2025 (Usd Million)
Table 105 Canada Injectable Drug Delivery Devices Market, By Product Type, 2016 – 2025 (Usd Million)
Table 106 Canada Conventional Injectable Drug Delivery Device Market, By Material,2016 – 2025 (Usd Million)
Table 107 Canada Conventional Injectable Drug Delivery Device Market, By Product Type,2016 – 2025 (Usd Million)
Table 108 Canada Conventional Injectable Drug Delivery Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 109 Canada Self Injection Device Market, By Type, 2016 – 2025 (Usd Million)
Table 110 Canada Needle Free Injectors (Nfi) Device Market, By Product,2016 – 2025 (Usd Million)
Table 111 Canada Needle Free Injectors (Nfi) Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 112 Canada Needle Free Injectors (Nfi) Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 113 Canada Auto Injectorsdevice Market, By Product, 2016 – 2025 (Usd Million)
Table 114 Canada Auto Injectors Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 115 Canada Auto Injectors Device Market, By Design, 2016 – 2025 (Usd Million)
Table 116 Canada Auto Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 117 Canada Pen Injectors Device Market, By Product, 2016 – 2025 (Usd Million)
Table 118 Canada Pen Injectors Device Market, By Design, 2016 – 2025 (Usd Million)
Table 119 Canada Pen Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 120 Canada Injectable Drug Delivery Formulation Market, By Product Type, 2016– 2025 (Usd Million)
Table 121 Canada Conventionaldrug Delivery Formulations, By Product Type 2016 – 2025 (Usd Million)
Table 122 Canada Noveldrug Delivery Formulations, By Producttype 2016 – 2025 (Usd Million)
Table 123 Canada Colloidaldispersion Drug Delivery Formulation, By Producttype 2016 – 2025 (Usd Million)
Table 124 Canada Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Product Type, 2016– 2025 (Usd Million)
Table 125 Canada Micro Particles Drug Delivery Formulations, By Product Type, 2016– 2025 (Usd Million)
Table 126 Canada Injectable Drug Delivery Market, By Application,2016 – 2025 (Usd Million)
Table 127 Canada Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Diseases Type, 2016 – 2025 (Usd Million)
Table 128 Canada Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016 – 2025 (Usd Million)
Table 129 Canada Others Injectable Drug Delivery Market, By Others Type, 2016 – 2025 (Usd Million)
Table 130 Canada Injectable Drug Delivery Market, By Usage Pattern, 2016– 2025 (Usd Million)
Table 131 Canada Injectable Drug Delivery Market, By Mode Of Administration, 2016– 2025 (Usd Million)
Table 132 Canada Injectable Drug Delivery Market, By End User, 2016– 2025 (Usd Million)
Table 133 Canada Injectable Drug Delivery Market, By Distribution Channel 2016– 2025 (Usd Million)
Table 134 Mexico Injectable Drug Delivery Market, By Producttype, 2016 – 2025 (Usd Million)
Table 135 Mexico Injectable Drug Delivery Devices Market, By Product Type, 2016 – 2025 (Usd Million)
Table 136 Mexico Conventional Injectable Drug Delivery Device Market, By Material,2016 – 2025 (Usd Million)
Table 137 Mexico Conventional Injectable Drug Delivery Device Market, By Product Type, 2016 – 2025 (Usd Million)
Table 138 Mexico Conventional Injectable Drug Delivery Device Market, By Usability, 2016 – 2025(Usd Million)
Table 139 Mexico Self Injection Device Market, By Type, 2016 – 2025 (Usd Million)
Table 140 Mexico Needle Free Injectors (Nfi) Device Market, By Product,2016 – 2025 (Usd Million)
Table 141 Mexico Needle Free Injectors (Nfi) Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 142 Mexico Needle Free Injectors (Nfi) Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 143 Mexico Auto Injectorsdevice Market, By Product, 2016 – 2025 (Usd Million)
Table 144 Mexico Auto Injectors Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 145 Mexico Auto Injectors Device Market, By Design, 2016 – 2025 (Usd Million)
Table 146 Mexico Auto Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 147 Mexico Pen Injectors Device Market, By Product, 2016 – 2025 (Usd Million)
Table 148 Mexico Pen Injectors Device Market, By Design, 2016 – 2025 (Usd Million)
Table 149 Mexico Pen Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 150 Mexico Injectable Drug Delivery Formulation Market, By Product Type, 2016– 2025 (Usd Million)
Table 151 Mexico Conventionaldrug Delivery Formulations, By Producttype 2016 – 2025 (Usd Million)
Table 152 Mexico Noveldrug Delivery Formulations, By Product Type 2016 – 2025 (Usd Million)
Table 153 Mexico Colloidaldispersion Drug Delivery Formulation, By Producttype 2015 – 2024 (Usd Million)
Table 154 Mexico Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Product Type, 2016– 2025 (Usd Million)
Table 155 Mexico Micro Particles Drug Delivery Formulations, By Product Type, 2016– 2025 (Usd Million)
Table 156 Mexico Injectable Drug Delivery Market, By Application,2016 – 2025 (Usd Million)
Table 157 Mexico Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Disease Type, 2016 – 2025 (Usd Million)
Table 158 Mexico Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016 – 2025 (Usd Million)
Table 159 Mexico Others Injectable Drug Delivery Market, By Others Type, 2016 – 2025 (Usd Million)
Table 160 Mexico Injectable Drug Delivery Market, By Usage Pattern, 2016– 2025 (Usd Million)
Table 161 Mexico Injectable Drug Delivery Market, By Mode Of Administration, 2016– 2025 (Usd Million)
Table 162 Mexico Injectable Drug Delivery Market, By End User, 2016– 2025 (Usd Million)
Table 163 Mexico Injectable Drug Delivery Market, By Distribution Channel 2016– 2025 (Usd Million)
Table 1 Examples Of Technological Advancements ()(2013- 2017)
Table 2 List Of Product Recall Drugs
Table 3 North America Injectable Drug Delivery Market, By Type, 2016 – 2025(Usd Million)
Table 4 North America Injectable Drug Delivery Devices Market, By Type, 2016 – 2025 (Usd Million)
Table 5 North America Conventional Drug Delivery Market, By Material, 2016 – 2025 (Usd Million)
Table 6 North America Conventional Drug Delivery Market, By Product, 2016 – 2025 (Usd Million)
Table 7 North America Conventional Drug Delivery Market, By Usability, 2016 – 2025(Usd Million)
Table 8 North America Self Injection Devices Market, By Product Type, 2016 – 2025 (Usd Million)
Table 9 North America Needle Free Injector Devices Market, By Product, 2016 – 2025 (Usd Million)
Table 10 North America Needle Free Injector Devices Market, By Technology, 2016– 2025 (Usd Million)
Table 11 North America Needle Free Injectors Device Arket, By Usability, 2016 – 2025 (Usd Million)
Table 12 North America Auto Injector Devices Market, By Product, 2016 – 2025 (Usd Million)
Table 13 North America Auto Injector Devices Market, By Technology, 2016 – 2025 (Usd Million)
Table 14 North America Auto Injector Devices Market, By Design, 2016 – 2025 (Usd Million)
Table 15 North America Auto Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 16 North America Pen Injector Devices Market, By Product, 2016 – 2025 (Usd Million)
Table 17 North America Pen Injector Devices Market, By Design, 2016 – 2025 (Usd Million)
Table 18 North America Pen Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 19 North America Injectable Drug Delivery Formulation Market, By Type, 2016 – 2025 (Usd Million)
Table 20 List Of Some Of The Lyophilized Formulations
Table 21 List Of Some Of The Emulsions
Table 22 North America Conventional Drug Delivery Formulation Market, By Product Type, 2016– 2025 (Usd Million)
Table 23 North America Novel Drug Delivery Formulation Market, By Product Type,2016 – 2025 (Usd Million)
Table 24 North America Colloidal Novel Drug Delivery Formulation Market, By Product Type, 20156– 2025 (Usd Million)
Table 25 List Of Some Of The Niosomes
Table 26 List Of Some Of The Liposomes
Table 27 List Of Some Of The Polymeric Mixed Micelles Drug Manufacturer
Table 28 List Of Nanosuspension Drug Manufacturer
Table 29 List Of Some Of The Nanoemulsions/Microemulsions Drug Manufacturer
Table 30 List Of Some Of The Solid Lipid Nanoparticles Drug Manufacturer
Table 31 North America Nanoparticle Colloidal Drug Delivery Formulation Market, By Product, 2016 – 2025 (Usd Million)
Table 32 List Of Some Of The Microspheres Drug Manufacturer
Table 33 North America Microparticles Colloidal Novel Drug Delivery Formulation Market, By Product Type, 20156– 2025 (Usd Million)
Table 34 List Of Some Of The First Generation Long Acting Injection
Table 35 List Of Some Of The Second Generation Long Acting Injection:
Table 36 North America Injectable Drug Delivery Application Market, By Application, 2016 – 2025 (Usd Million)
Table 37 North America Injectable Drug Delivery Application Market, By Hormonal Disorders Type, 2016 – 2025 (Usd Billion)
Table 38 North America Autoimmune Disease Injectable Drug Delivery Application Market, By Autoimmune Disease Type, 2016 – 2025 (Usd Billion)
Table 39 List Of Orphan Disease In India (2010)
Table 40 North America Others Injectable Drug Delivery Application Market, By Others Type, 2016 – 2025 (Usd Billion)
Table 41 North Americainjectable Drug Delivery Usage Pattern Market, By Type, 2015 – 2024 (Usd Million)
Table 42 North America Injectable Drug Delivery Market, By Mode Of Administration, 2016 – 2025 (Usd Million)
Table 43 North America Injectable Drug Delivery Market, By End User, 2016– 2025 (Usd Million)
Table 44 North America Injectable Drug Delivery Market, By Distribution Channel, 2016 – 2025 (Usd Million)
Table 45 North America Injectable Drug Delivery Market, By Country, 2016 – 2025 (Usd Million)
Table 46 North America Injectable Drug Delivery Market, By Type, 2016 – 2025 (Usd Million)
Table 47 North America Injectable Drug Delivery Devices Market, By Product Type, 2016 – 2025 (Usd Million)
Table 48 North America Conventional Injectable Drug Delivery Device Market, By Material,2016 – 2025 (Usd Million)
Table 49 North America Conventional Injectable Drug Delivery Device Market, By Product Type, 2016 – 2025 (Usd Million)
Table 50 North America Conventional Injectable Drug Delivery Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 51 North America Self Injection Device Market, By Type,2016 – 2025 (Usd Million)
Table 52 North America Needle Free Injectors (Nfi) Device Market, By Product,2016 – 2025 (Usd Million)
Table 53 North America Needle Free Injectors (Nfi) Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 54 North America Needle Free Injectors (Nfi) Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 55 North America Auto Injectorsdevice Market, By Product, 2016 – 2025 (Usd Million)
Table 56 North America Auto Injectors Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 57 North America Auto Injectors Device Market, By Design, 2016 – 2025 (Usd Million)
Table 58 North America Auto Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 59 North America Pen Injectors Device Market, By Product, 2016 – 2025 (Usd Million)
Table 60 North America Pen Injectors Device Market, By Design,2016– 2025 (Usd Million)
Table 61 North America Pen Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 62 North America Injectable Drug Delivery Formulation Market, By Type, 2016– 2025 (Usd Million)
Table 63 North America Conventionaldrug Delivery Formulations, By Product Type 2016 – 2025 (Usd Million)
Table 64 North America Noveldrug Delivery Formulations, By Product Type, 2016 – 2025 (Usd Million)
Table 65 North America Colloidaldispersion Drug Delivery Formulation, By Product Type,20156– 2025 (Usd Million)
Table 66 North America Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Type, 2016– 2025 (Usd Million)
Table 67 North America Micro Particles Drug Delivery Formulations, By Type, 2016– 2025 (Usd Million)
Table 68 North America Injectable Drug Delivery Market, By Application, 2016 – 2025 (Usd Million)
Table 69 North America Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Disease Type, 2016 – 2025 (Usd Million)
Table 70 North America Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016 – 2025 (Usd Million)
Table 71 North America Others Injectable Drug Delivery Market, By Others Type, 2016 – 2025 (Usd Million)
Table 72 North America Injectable Drug Delivery Market, By Usage Pattern, 2016– 2025 (Usd Million)
Table 73 North America Injectable Drug Delivery Market, By Mode Of Administration, 2016– 2025 (Usd Million)
Table 74 North America Injectable Drug Delivery Market, By End User, 2016– 2025 (Usd Million)
Table 75 North America Injectable Drug Delivery Market, By Distribution Channel, 2016– 2025 (Usd Million)
Table 76 U.S. Injectable Drug Delivery Market, By Product Type, 2016 – 2025 (Usd Million)
Table 77 U.S. Injectable Drug Delivery Devices Market, By Product Type, 2016 – 2025 (Usd Million)
Table 78 U.S. Conventional Injectable Drug Delivery Device Market, By Product Type,2016 – 2025 (Usd Million)
Table 79 U.S. Conventional Injectable Drug Delivery Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 80 U.S. Self Injection Device Market, By Type, 2016 – 2025 (Usd Million)
Table 81 U.S. Needle Free Injectors (Nfi) Device Market, By Product,2016 – 2025 (Usd Million)
Table 82 U.S. Needle Free Injectors (Nfi) Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 83 U.S. Needle Free Injectors (Nfi) Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 84 U.S. Auto Injectorsdevice Market, By Product, 2016 – 2025 (Usd Million)
Table 85 U.S. Auto Injectors Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 86 U.S. Auto Injectors Device Market, By Design, 2016 – 2025 (Usd Million)
Table 87 U.S. Auto Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 88 U.S. Pen Injectors Device Market, By Product, 2016 – 2025 (Usd Million)
Table 89 U.S. Pen Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 90 U.S. Injectable Drug Delivery Formulation Market, By Product Type, 2016– 2025 (Usd Million)
Table 91 U.S. Conventionaldrug Delivery Formulations, By Product Type 2016 – 2025 (Usd Million)
Table 92 U.S. Noveldrug Delivery Formulations, By Product Type 2016 – 2025 (Usd Million)
Table 93 U.S. Colloidaldispersion Drug Delivery Formulation, By Product Type, 2016 – 2025 (Usd Million)
Table 94 U.S. Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Product Type, 2016– 2025 (Usd Million)
Table 95 U.S. Micro Particles Drug Delivery Formulations, By Product Type, 2016– 2025 (Usd Million)
Table 96 U.S. Injectable Drug Delivery Market, By Application,2016 – 2025 (Usd Million)
Table 97 U.S. Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Disease Type, 20156– 2025 (Usd Million)
Table 98 U.S. Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016 – 2025 (Usd Million)
Table 99 U.S. Others Injectable Drug Delivery Market, By Others Type, 2016 – 2025 (Usd Million)
Table 100 U.S. Injectable Drug Delivery Market, By Usage Pattern, 2016– 2025 (Usd Million)
Table 101 U.S. Injectable Drug Delivery Market, By Mode Of Administration, 2016– 2025 (Usd Million)
Table 102 U.S. Injectable Drug Delivery Market, By End User, 2016– 2025 (Usd Million)
Table 103 U.S. Injectable Drug Delivery Market, By Distribution Channel 2016– 2025 (Usd Million)
Table 104 Canada Injectable Drug Delivery Market, By Type, 20156– 2025 (Usd Million)
Table 105 Canada Injectable Drug Delivery Devices Market, By Product Type, 2016 – 2025 (Usd Million)
Table 106 Canada Conventional Injectable Drug Delivery Device Market, By Material,2016 – 2025 (Usd Million)
Table 107 Canada Conventional Injectable Drug Delivery Device Market, By Product Type,2016 – 2025 (Usd Million)
Table 108 Canada Conventional Injectable Drug Delivery Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 109 Canada Self Injection Device Market, By Type, 2016 – 2025 (Usd Million)
Table 110 Canada Needle Free Injectors (Nfi) Device Market, By Product,2016 – 2025 (Usd Million)
Table 111 Canada Needle Free Injectors (Nfi) Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 112 Canada Needle Free Injectors (Nfi) Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 113 Canada Auto Injectorsdevice Market, By Product, 2016 – 2025 (Usd Million)
Table 114 Canada Auto Injectors Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 115 Canada Auto Injectors Device Market, By Design, 2016 – 2025 (Usd Million)
Table 116 Canada Auto Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 117 Canada Pen Injectors Device Market, By Product, 2016 – 2025 (Usd Million)
Table 118 Canada Pen Injectors Device Market, By Design, 2016 – 2025 (Usd Million)
Table 119 Canada Pen Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 120 Canada Injectable Drug Delivery Formulation Market, By Product Type, 2016– 2025 (Usd Million)
Table 121 Canada Conventionaldrug Delivery Formulations, By Product Type 2016 – 2025 (Usd Million)
Table 122 Canada Noveldrug Delivery Formulations, By Producttype 2016 – 2025 (Usd Million)
Table 123 Canada Colloidaldispersion Drug Delivery Formulation, By Producttype 2016 – 2025 (Usd Million)
Table 124 Canada Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Product Type, 2016– 2025 (Usd Million)
Table 125 Canada Micro Particles Drug Delivery Formulations, By Product Type, 2016– 2025 (Usd Million)
Table 126 Canada Injectable Drug Delivery Market, By Application,2016 – 2025 (Usd Million)
Table 127 Canada Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Diseases Type, 2016 – 2025 (Usd Million)
Table 128 Canada Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016 – 2025 (Usd Million)
Table 129 Canada Others Injectable Drug Delivery Market, By Others Type, 2016 – 2025 (Usd Million)
Table 130 Canada Injectable Drug Delivery Market, By Usage Pattern, 2016– 2025 (Usd Million)
Table 131 Canada Injectable Drug Delivery Market, By Mode Of Administration, 2016– 2025 (Usd Million)
Table 132 Canada Injectable Drug Delivery Market, By End User, 2016– 2025 (Usd Million)
Table 133 Canada Injectable Drug Delivery Market, By Distribution Channel 2016– 2025 (Usd Million)
Table 134 Mexico Injectable Drug Delivery Market, By Producttype, 2016 – 2025 (Usd Million)
Table 135 Mexico Injectable Drug Delivery Devices Market, By Product Type, 2016 – 2025 (Usd Million)
Table 136 Mexico Conventional Injectable Drug Delivery Device Market, By Material,2016 – 2025 (Usd Million)
Table 137 Mexico Conventional Injectable Drug Delivery Device Market, By Product Type, 2016 – 2025 (Usd Million)
Table 138 Mexico Conventional Injectable Drug Delivery Device Market, By Usability, 2016 – 2025(Usd Million)
Table 139 Mexico Self Injection Device Market, By Type, 2016 – 2025 (Usd Million)
Table 140 Mexico Needle Free Injectors (Nfi) Device Market, By Product,2016 – 2025 (Usd Million)
Table 141 Mexico Needle Free Injectors (Nfi) Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 142 Mexico Needle Free Injectors (Nfi) Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 143 Mexico Auto Injectorsdevice Market, By Product, 2016 – 2025 (Usd Million)
Table 144 Mexico Auto Injectors Device Market, By Technology, 2016 – 2025 (Usd Million)
Table 145 Mexico Auto Injectors Device Market, By Design, 2016 – 2025 (Usd Million)
Table 146 Mexico Auto Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 147 Mexico Pen Injectors Device Market, By Product, 2016 – 2025 (Usd Million)
Table 148 Mexico Pen Injectors Device Market, By Design, 2016 – 2025 (Usd Million)
Table 149 Mexico Pen Injectors Device Market, By Usability, 2016 – 2025 (Usd Million)
Table 150 Mexico Injectable Drug Delivery Formulation Market, By Product Type, 2016– 2025 (Usd Million)
Table 151 Mexico Conventionaldrug Delivery Formulations, By Producttype 2016 – 2025 (Usd Million)
Table 152 Mexico Noveldrug Delivery Formulations, By Product Type 2016 – 2025 (Usd Million)
Table 153 Mexico Colloidaldispersion Drug Delivery Formulation, By Producttype 2015 – 2024 (Usd Million)
Table 154 Mexico Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Product Type, 2016– 2025 (Usd Million)
Table 155 Mexico Micro Particles Drug Delivery Formulations, By Product Type, 2016– 2025 (Usd Million)
Table 156 Mexico Injectable Drug Delivery Market, By Application,2016 – 2025 (Usd Million)
Table 157 Mexico Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Disease Type, 2016 – 2025 (Usd Million)
Table 158 Mexico Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016 – 2025 (Usd Million)
Table 159 Mexico Others Injectable Drug Delivery Market, By Others Type, 2016 – 2025 (Usd Million)
Table 160 Mexico Injectable Drug Delivery Market, By Usage Pattern, 2016– 2025 (Usd Million)
Table 161 Mexico Injectable Drug Delivery Market, By Mode Of Administration, 2016– 2025 (Usd Million)
Table 162 Mexico Injectable Drug Delivery Market, By End User, 2016– 2025 (Usd Million)
Table 163 Mexico Injectable Drug Delivery Market, By Distribution Channel 2016– 2025 (Usd Million)
LIST OF FIGURES
Figure 1 North America Injectable Drug Delivery Market: Segmentation
Figure 2 North America Injectable Drug Delivery Market: Geographic Scope
Figure 3 North America Injectable Drug Delivery Market: Data Triangulation
Figure 4 North America Injectable Drug Delivery Market: Research Snapshot
Figure 5 North America Injectable Drug Delivery Market: Bottom Up Approach
Figure 6 North America Injectable Drug Delivery Market: Top Down Approach
Figure 7 North America Injectable Drug Delivery Market: Interview Demographics
Figure 8 Figure: Drivers, Restraints, Opportunities, And Challenges Of The Injectable Drug Delivery Market
Figure 9 Number Of Needlestick Injuries
Figure 10 Technological Development And Increasing Prevalence Of Chronic Diseases Are Expected To Drive The Market For Injectable Drug Delivery In The Forecast Period 2018 To 2025
Figure 11 Injectable Drug Delivery Formulation Market Segment Is Expected To Account For The Largest Share Of The North America Injectable Drug Delivery Market In 2018 & 2025
Figure 12 North America Is The Highest Growing And Most Profitable Revenue Pockets For Injectable Drug Delivery Manufacturers In The Forecast Period To 2025
Figure 13 North America Injectable Drug Delivery Market: By Type, Snapshot 2016
Figure 14 North America Injectable Drug Delivery Market: By Application, Snapshot 2017
Figure 15 North America Injectable Drug Delivery Market: By Usage Pattern, Snapshot 2017
Figure 16 North America Injectable Drug Delivery Market: By Mode Of Administration, Snapshot 2017
Figure 17 North America Injectable Drug Delivery Market Dominated By Hospital And Cliinics Segment
Figure 18 North America Injectable Drug Deliverymarket: By End-User, Snapshot 2017
Figure 19 North America Injectable Drug Delivery Market: By Distribution Channel, Snapshot 2017
Figure 20 North America Injectable Drug Delivery Market Snapshot (2017)
Figure 21 North America Injectable Drug Delivery Market: Company Share 2017 (%)
Figure 22 Becton, Dickinson And Company: Swot (Strength, Weakness, Opportunities And Threats)
Figure 23 Becton, Dickinsom And Company: Revenue Analysis
Figure 24 Pfizer, Inc.: Swot (Strength, Weakness, Opportunities And Threats)
Figure 25 Pfizer, Inc.: Revenue Analysis
Figure 26 Baxter International Inc.: Swot (Strength, Weakness, Opportunities And Threats)
Figure 27 Baxter International, Inc.: Revenue Analysis
Figure 28 Gerresheimer Ag: Revenue Analysis
Figure 29 Schott Ag Inc.: Revenue Analysis
Figure 30 Alkermes Inc.: Revenue Analysis
Figure 31 Antares Pharma: Revenue Analysis
Figure 32 Bespak: Revenue Analysis
Figure 33 Elcam Medical: Revenue Analysis
Figure 34 Eli Lilly And Company: Swot (Strength, Weakness, Opportunities And Threats)
Figure 35 Eli Lilly And Company: Revenue Analysis
Figure 36 Haselmeier: Revenue Analysis
Figure 37 Mylan N.V.: Revenue Analysis
Figure 38 Novo Nordisk: Revenue Analysis
Figure 39 Owen Mumford Ltd: Revenue Analysis
Figure 40 Sandoz International Gmbh: Revenue Analysis
Figure 41 Sanofi: Revenue Analysis
Figure 42 Terumo Corporation: Revenue Analysis
Figure 43 Teva Pharmaceutical: Swot (Strength, Weakness, Opportunities And Threats)
Figure 44 Teva Pharmaceutical: Revenue Analysis
Figure 45 West Pharmaceutical Services, Inc: Revenue Analysis
Figure 46 Ypsomed Holding Ag: Revenue Analysis
Figure 1 North America Injectable Drug Delivery Market: Segmentation
Figure 2 North America Injectable Drug Delivery Market: Geographic Scope
Figure 3 North America Injectable Drug Delivery Market: Data Triangulation
Figure 4 North America Injectable Drug Delivery Market: Research Snapshot
Figure 5 North America Injectable Drug Delivery Market: Bottom Up Approach
Figure 6 North America Injectable Drug Delivery Market: Top Down Approach
Figure 7 North America Injectable Drug Delivery Market: Interview Demographics
Figure 8 Figure: Drivers, Restraints, Opportunities, And Challenges Of The Injectable Drug Delivery Market
Figure 9 Number Of Needlestick Injuries
Figure 10 Technological Development And Increasing Prevalence Of Chronic Diseases Are Expected To Drive The Market For Injectable Drug Delivery In The Forecast Period 2018 To 2025
Figure 11 Injectable Drug Delivery Formulation Market Segment Is Expected To Account For The Largest Share Of The North America Injectable Drug Delivery Market In 2018 & 2025
Figure 12 North America Is The Highest Growing And Most Profitable Revenue Pockets For Injectable Drug Delivery Manufacturers In The Forecast Period To 2025
Figure 13 North America Injectable Drug Delivery Market: By Type, Snapshot 2016
Figure 14 North America Injectable Drug Delivery Market: By Application, Snapshot 2017
Figure 15 North America Injectable Drug Delivery Market: By Usage Pattern, Snapshot 2017
Figure 16 North America Injectable Drug Delivery Market: By Mode Of Administration, Snapshot 2017
Figure 17 North America Injectable Drug Delivery Market Dominated By Hospital And Cliinics Segment
Figure 18 North America Injectable Drug Deliverymarket: By End-User, Snapshot 2017
Figure 19 North America Injectable Drug Delivery Market: By Distribution Channel, Snapshot 2017
Figure 20 North America Injectable Drug Delivery Market Snapshot (2017)
Figure 21 North America Injectable Drug Delivery Market: Company Share 2017 (%)
Figure 22 Becton, Dickinson And Company: Swot (Strength, Weakness, Opportunities And Threats)
Figure 23 Becton, Dickinsom And Company: Revenue Analysis
Figure 24 Pfizer, Inc.: Swot (Strength, Weakness, Opportunities And Threats)
Figure 25 Pfizer, Inc.: Revenue Analysis
Figure 26 Baxter International Inc.: Swot (Strength, Weakness, Opportunities And Threats)
Figure 27 Baxter International, Inc.: Revenue Analysis
Figure 28 Gerresheimer Ag: Revenue Analysis
Figure 29 Schott Ag Inc.: Revenue Analysis
Figure 30 Alkermes Inc.: Revenue Analysis
Figure 31 Antares Pharma: Revenue Analysis
Figure 32 Bespak: Revenue Analysis
Figure 33 Elcam Medical: Revenue Analysis
Figure 34 Eli Lilly And Company: Swot (Strength, Weakness, Opportunities And Threats)
Figure 35 Eli Lilly And Company: Revenue Analysis
Figure 36 Haselmeier: Revenue Analysis
Figure 37 Mylan N.V.: Revenue Analysis
Figure 38 Novo Nordisk: Revenue Analysis
Figure 39 Owen Mumford Ltd: Revenue Analysis
Figure 40 Sandoz International Gmbh: Revenue Analysis
Figure 41 Sanofi: Revenue Analysis
Figure 42 Terumo Corporation: Revenue Analysis
Figure 43 Teva Pharmaceutical: Swot (Strength, Weakness, Opportunities And Threats)
Figure 44 Teva Pharmaceutical: Revenue Analysis
Figure 45 West Pharmaceutical Services, Inc: Revenue Analysis
Figure 46 Ypsomed Holding Ag: Revenue Analysis
